- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
49
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
49 companies
Sotera Health
Market Cap: US$4.9b
Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$17.37
7D
10.1%
1Y
32.6%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥11.8b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥17.07
7D
-1.3%
1Y
1.2%
PharmaEssentia
Market Cap: NT$186.4b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$504.00
7D
11.1%
1Y
-1.4%
AbbVie
Market Cap: US$405.6b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$231.80
7D
-0.9%
1Y
28.0%
BioLife Solutions
Market Cap: US$1.3b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$26.99
7D
12.3%
1Y
-0.3%
Caris Life Sciences
Market Cap: US$7.1b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$25.58
7D
7.7%
1Y
n/a
Sawai Group Holdings
Market Cap: JP¥223.9b
Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.
4887
JP¥1,939.00
7D
3.0%
1Y
-5.5%
Hypera
Market Cap: R$16.0b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$25.40
7D
-1.2%
1Y
24.9%
Immutep
Market Cap: AU$397.4m
A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.27
7D
3.8%
1Y
-12.9%
Neurocrine Biosciences
Market Cap: US$14.1b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$143.53
7D
3.5%
1Y
12.2%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.70
7D
0.3%
1Y
-8.3%
Consun Pharmaceutical Group
Market Cap: HK$12.6b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$14.94
7D
4.6%
1Y
89.8%
Telix Pharmaceuticals
Market Cap: AU$5.1b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$15.03
7D
7.8%
1Y
-35.7%
Shanghai OPM Biosciences
Market Cap: CN¥6.3b
Provides cell culture media and CDMO services in China and internationally.
688293
CN¥55.60
7D
-3.6%
1Y
30.3%
BioGaia
Market Cap: SEK 10.1b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 100.50
7D
0%
1Y
-5.3%
Daiichi Sankyo Company
Market Cap: JP¥7.1t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥3,862.00
7D
9.5%
1Y
-16.8%
Akeso
Market Cap: HK$111.1b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$120.60
7D
7.9%
1Y
55.5%
Camurus
Market Cap: SEK 36.3b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 620.00
7D
-0.08%
1Y
12.0%
AstraZeneca
Market Cap: UK£218.7b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£141.48
7D
4.1%
1Y
34.3%
Sandoz Group
Market Cap: CHF 24.1b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 56.16
7D
4.2%
1Y
38.4%
AprilBioLtd
Market Cap: ₩894.5b
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
A397030
₩38,950.00
7D
1.2%
1Y
137.5%
Indoco Remedies
Market Cap: ₹24.1b
Manufactures and markets formulations and active pharmaceutical ingredients in India and internationally.
INDOCO
₹261.30
7D
0.4%
1Y
-14.5%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$105.6b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$453.00
7D
5.6%
1Y
131.1%
ST PharmLtd
Market Cap: ₩2.1t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩103,600.00
7D
5.0%
1Y
24.5%
Rhythm Pharmaceuticals
Market Cap: US$7.3b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$108.75
7D
5.4%
1Y
74.7%
Beijing Aosaikang Pharmaceutical
Market Cap: CN¥16.0b
Beijing Aosaikang Pharmaceutical Co., Ltd.
002755
CN¥17.28
7D
-0.6%
1Y
25.2%
Ligand Pharmaceuticals
Market Cap: US$4.0b
A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
LGND
US$203.52
7D
-1.2%
1Y
66.1%
Avadel Pharmaceuticals
Market Cap: US$2.2b
Operates as a biopharmaceutical company in the United States.
AVDL
US$22.93
7D
-0.04%
1Y
105.7%
InnoCare Pharma
Market Cap: HK$28.8b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$14.85
7D
1.7%
1Y
121.3%
Alnylam Pharmaceuticals
Market Cap: US$57.4b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$429.80
7D
-7.0%
1Y
69.6%
Galderma Group
Market Cap: CHF 36.9b
Operates as a dermatology company worldwide.
GALD
CHF 158.60
7D
7.5%
1Y
78.7%
Solara Active Pharma Sciences
Market Cap: ₹25.2b
Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.
SOLARA
₹523.75
7D
-8.1%
1Y
-36.4%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.4b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€50.55
7D
0.7%
1Y
-2.2%
Vitrolife
Market Cap: SEK 20.3b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 150.70
7D
6.1%
1Y
-33.0%
Strides Pharma Science
Market Cap: ₹83.2b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹903.10
7D
-6.2%
1Y
-40.9%
Simcere Pharmaceutical Group
Market Cap: HK$36.0b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$13.87
7D
7.3%
1Y
103.4%